Company: SCLXW
Filing Date: 2025-08-14
Form Type: 424B3
Source: 0000950170-25-108226
Chunk: 61

Company: Scilex Holding Co
Filing Date: 2025-08-14
Form: 424B3
Chunk 61
---
x Holding Company 2019 Stock Option Plan (the “2019 Stock Option Plan”), which subsequently was amended in December 2020. The 2019 Stock Option Plan was terminated at the closing of the Business Combination, and no further awards have been granted under the 2019 Stock Option Plan thereafter. However, the 2019 Stock Option Plan will continue to govern outstanding awards granted thereunder.

<div align='center'>32</div>

Scilex Holding Company 2022 Equity Incentive Plan In October 2022, the Board adopted the Scilex Holding Company 2022 Equity Incentive Plan (the “Equity Incentive Plan”). As of June 30, 2025, a total of 716,085 shares of Common Stock were available and have been reserved for future issuance under the Equity Incentive Plan. Scilex Holding Company 2023 Inducement Plan On January 17, 2023, the compensation committee of the Board adopted the Scilex Holding Company 2023 Inducement Plan (the “Inducement Plan”). The Inducement Plan provides for the grant of equity-based awards in the form of non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, and other awards solely to prospective employees of the Company or an affiliate of the Company provided that certain criteria are met. The initial maximum number of shares available for grant under the Inducement Plan is 40,000 shares of Common Stock (subject to adjustment for recapitalizations, stock splits, reorganizations and similar transactions). No awards were granted under the Inducement Plan during the six months ended June 30, 2025 and 2024. As of June 30, 2025, options to purchase 1,009,938 shares of Common Stock were outstanding under all equity incentive plans. The following table summarizes stock option activity during the six months ended June 30, 2025 (in thousands, except for per share amounts and contractual life):

|                                                 | Options |       |   |     | Weighted-Average Exercise Price |        |     | Weighted-Average            
 Remaining Contractual Life, 
 in years                    |     |     | Aggregate Intrinsic Value |   |
|:------------------------------------------------|:--------|------:|:--|:----|:--------------------------------|-------:|:----|:----------------------------|----:|:----|:--------------------------|--:|
| Outstanding as of December 31, 2024